According to data from the 2019 CF Foundation Patient Registry, more than 50% of adults with cystic fibrosis experience sinus disease, in addition to more than 20% of adolescents with CF.
Management of complications secondary to CF, such as sinus disease, is important for maintaining an individual’s health and quality of life. Watch our sinus disease research webinar to hear Daniel Beswick, MD, from @UCLA, Anna Zemke, MD, PhD, from the @University of Pittsburgh, and Eliza Callard, an adult with CF, discuss this important topic including studies looking at the impact of highly effective modulators on sinus disease and sinus surgery outcomes.
Originally recorded August 25, 2021.
0:00 | Research overview: sinus disease